Submitted by dcc on Fri, 2018-12-07 14:48 Study Title: A Phase II Randomized Study of Adjuvant versus Neoadjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Sage III-IV High Risk MelanomaCIRB: Adult CIRB - Late Phase EmphasisLead Group: SWOGStatus: ActiveReview Status: Available to Open
